BUY Hindalco Industries Ltd. — Rajesh Palviya, Axis Securities
byRajesh Palviya, Axis SecuritiesHorizon: 1–3 months7 Apr 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
6 advisors have active long-term BUY calls on this stock, with 3 issued in the last 14 days
Advisor consensus · adjacent horizon·9 Apr · 5d ago
1 other SEBI-registered advisor has an active short-term BUY call on this stock, issued in the last 14 days
Advisor consensus · same horizon·7 Apr · 1w ago
Nothing found in this tip’s window yet.
1 advisor has an active long-term SELL call on this stock
Advisor consensus · adjacent horizon·5 Nov · 5mo ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Hindalco Industries
- BUY — Nomura India Research22 Oct 2026 · ~1 year · target ₹1,100 · Active
- BUY — Motilal Oswal21 Oct 2026 · ~1 year · target ₹1,170 · Active
- BUY — Vaishali Parekh, Prabhudas Lilladher19 Oct 2026 · ~2 weeks · target ₹960 · Active
- BUY — Pradip Hotchandani, Prudent Corporate Advisory Services19 Oct 2026 · ~2 weeks · target ₹960 · SL hit
- SELL — Raja Venkatraman9 Oct 2026 · ~3 months · target ₹815 · Active
More from Rajesh Palviya, Axis Securities
- BUY Sansera Engineering8 Oct 2026 · ~2 weeks · target ₹4,350 · SL hit
- BUY Trent8 Oct 2026 · ~2 weeks · target ₹3,050 · SL hit
- SELL Sun Pharmaceutical Industries5 Oct 2026 · ~3 months · target ₹1,720 · SL hit
- BUY Cipla29 Sept 2026 · ~2 weeks · target ₹1,480 · SL hit
- BUY Zydus Lifesciences29 Sept 2026 · ~2 weeks · target ₹1,280 · SL hit

